Tools
Tools Overview & Help
Query by symbols/IDs
Batch Download
Sequence Downloader
ID Validator
Feature Mapper
Search/Browse Portals
QuickSearch
Vocabularies
QueryBuilder
CytoSearch
Interactions Browser
ImageBrowse
Genomics Tools
BLAST
JBrowse
CytoSearch
Feature Mapper
Chromosome Maps
Coordinates Converter
Sequence Downloader
modENCODE RNA-Seq
Overview
RNA-Seq Similarity
RNA-Seq Profile
RNA-Seq By Region
JBrowse
Submit Data
Fast-Track Your Paper
Submit Personal Communication
Feedback on Gene Snapshots
Downloads
Overview
Current Release
Archived Data
Map Conversion
FTP Site:
Releases (FTP)
Genomes (FTP)
Links
External Resources
Model Organisms (MODs)
Alliance of Genome Resources
BeeBase
DictyBase
EcoCyc
Gramene
MGI
PomBase
Pseudobase
RGD
SGD
TAIR
VectorBase
WormBase
Xenbase
ZFIN
Stock Collections
Bloomington Drosophila Stock Center (BDSC)
FlyORF
Korea Drosophila Resource Center (KDRC)
Kyoto Stock Center
NIG-FLY
Tsinghua Fly Center (THFC)
Vienna Drosophila Resource Center (VDRC)
BDGP
DGRC
DRSC/TRiP
DIS by issue
FlyBook
FlyExpress
Interactive Fly
Virtual Fly Brain
FlyCyc
Community
Fast-Track Your Paper
FlyBase Community
Advisory Group
Fly Lab List
Recent Papers With
Technical Advances
Gene Snapshots
FlyBase Forum
Newsletter
FlySlack Community
Mastodon
Bluesky
X (formerly Twitter)
Fly Board
NIH Funding
Species
Phylogeny
Sequenced Species
Synteny Table
Color Illustrations
About
Release Notes
New In This Release
Release Schedule
FlyBase Positions
Citing FlyBase
FlyBase Licensing
FlyBase Consortium
FlyBase Publications
FlyBase Presentations
Grants Supporting FlyBase
Help
Contact FlyBase
FlyBase Wiki:
Help Index
Tool help
Report help
FlyBase FAQ
Info for Authors
Author guidelines
Citing FlyBase
Fast-Track Your Paper Help
Gene Snapshots
Personal communications
Linking to/from FlyBase
Nomenclature
Curation documentation
Controlled Vocabularies in FlyBase
Gene Model Annotation
Gene Ontology (GO) Annotation
Nontraditional alleles
Vectors & Constructs
New to Flies?
Video Tutorials
FlyBase For Developers
Transgenic product class in Gene Reports
DIOPT Version 9.1 Update
Fly Lab List
Previous
Next
FB2024_02
,
released April 23, 2024
Tools
Tools Overview & Help
Query by symbols/IDs
Batch Download
Sequence Downloader
ID Validator
Feature Mapper
Search/Browse Portals
QuickSearch
Vocabularies
QueryBuilder
CytoSearch
Interactions Browser
ImageBrowse
Genomics Tools
BLAST
JBrowse
CytoSearch
Feature Mapper
Chromosome Maps
Coordinates Converter
Sequence Downloader
modENCODE RNA-Seq
Overview
RNA-Seq Similarity
RNA-Seq Profile
RNA-Seq By Region
JBrowse
Submit Data
Fast-Track Your Paper
Submit Personal Communication
Feedback on Gene Snapshots
Downloads
Overview
Current Release
Archived Data
Map Conversion
FTP Site:
Releases (FTP)
Genomes (FTP)
Links
External Resources
Model Organisms (MODs)
Alliance of Genome Resources
BeeBase
DictyBase
EcoCyc
Gramene
MGI
PomBase
Pseudobase
RGD
SGD
TAIR
VectorBase
WormBase
Xenbase
ZFIN
Stock Collections
Bloomington Drosophila Stock Center (BDSC)
FlyORF
Korea Drosophila Resource Center (KDRC)
Kyoto Stock Center
NIG-FLY
Tsinghua Fly Center (THFC)
Vienna Drosophila Resource Center (VDRC)
BDGP
DGRC
DRSC/TRiP
DIS by issue
FlyBook
FlyExpress
Interactive Fly
Virtual Fly Brain
FlyCyc
Community
Fast-Track Your Paper
FlyBase Community
Advisory Group
Fly Lab List
Recent Papers With
Technical Advances
Gene Snapshots
FlyBase Forum
Newsletter
FlySlack Community
Mastodon
Bluesky
X (formerly Twitter)
Fly Board
NIH Funding
Species
Phylogeny
Sequenced Species
Synteny Table
Color Illustrations
About
Release Notes
New In This Release
Release Schedule
FlyBase Positions
Citing FlyBase
FlyBase Licensing
FlyBase Consortium
FlyBase Publications
FlyBase Presentations
Grants Supporting FlyBase
Help
Contact FlyBase
FlyBase Wiki:
Help Index
Tool help
Report help
FlyBase FAQ
Info for Authors
Author guidelines
Citing FlyBase
Fast-Track Your Paper Help
Gene Snapshots
Personal communications
Linking to/from FlyBase
Nomenclature
Curation documentation
Controlled Vocabularies in FlyBase
Gene Model Annotation
Gene Ontology (GO) Annotation
Nontraditional alleles
Vectors & Constructs
New to Flies?
Video Tutorials
FlyBase For Developers
Transgenic product class in Gene Reports
DIOPT Version 9.1 Update
Fly Lab List
Previous
Next
FB2024_02
,
released April 23, 2024
Human Disease Model Report Index
J2G
Search
Go
FlyBase Human Disease Model Report Index
3-methylglutaconic aciduria
46,XX sex reversal 4
46,XY gonadal dysgenesis (postulated), STARD8-related
acute myeloid leukemia
acute myeloid leukemia, KRAS[G12V] model
acute myeloid leukemia, MLF1-related
acute myeloid leukemia, MLL-AF fusions
acute myeloid leukemia, NUP98-HOXA9 fusion
acute myeloid leukemia, RUNX1-RUNX1T1 fusion
acute myeloid leukemia models, RAS-Scrib-complex-related
acyl-CoA dehydrogenase, medium chain, deficiency of
Adams-Oliver syndrome 3
adenoid cystic carcinoma, multigenic, personalized
adrenoleukodystrophy, ABCD1-related
adrenoleukodystrophy (postulated), ACSBG-related
advanced sleep phase syndrome
familial advanced sleep phase syndrome 2
age-dependent ectopic fat accumulation, HDAC6-related
Alexander disease
alcohol use disorder, susceptibility to (fly models overview)
alcohol, developmental effects
alcohol, increased aggressive behavior
alcohol, response to, actin-mediated
alcohol, response to, AKAP-related
alcohol, response to, ARF6-related
alcohol, response to, ATG16L-related
alcohol, response to, AUTS2-related
alcohol, response to, cathepsin-related
alcohol, response to, CBP-related
alcohol, response to, Crz neuropeptide-related
alcohol, response to, Dmel_apt-related
alcohol, response to, dopamine receptor DRD1,5-related
alcohol, response to, dual-GPCR signaling
alcohol, response to, EGFR-MAPK/ERK signaling
alcohol, response to, EPS8-related
alcohol, response to, F-actin turnover-related
alcohol, response to, GABBR-related
alcohol, response to, GRK4,5,6-related
alcohol, response to, GSTO-related
alcohol, response to, HOMER-related
alcohol, response to, INSR-related
alcohol, response to, insulin signaling pathway
alcohol, response to, JmjC-domain-containing genes
alcohol, response to, KCNMA1-related
alcohol, response to, learning and memory genes
alcohol, response to, MAP4K-related
alcohol, response to, MEF2-related
alcohol, response to, microRNA-related
alcohol, response to, NMDA-receptor-mediated
alcohol, response to, NPY-related
alcohol, response to, PI3K-AKT signaling pathway
alcohol, response to, PSD-related
alcohol, response to, RhoGAP-related
alcohol, response to, RPS6KB-related
alcohol, response to, RSU1-related
alcohol, response to, RYR-related
alcohol, response to, stress-response genes
alcohol, response to, SIRT1-related
alcohol, response to, SLC39A8-related
alcohol, response to, UNC13A-related
alcohol, response to, XRCC5-related
persistent alcohol cue memory
Alpers-Huttenlocher syndrome
alpha-1-antitrypsin deficiency
Alzheimer disease
Alzheimer disease 1
Alzheimer disease 2
Alzheimer disease, APP-BACE1-related
Alzheimer disease, presenilin-related
Alzheimer disease 3
Alzheimer disease 4
Alzheimer disease, retromer dysfunction
Alzheimer disease, susceptibility to, CD2AP-related
Alzheimer disease, susceptibility to, FERMT2-related
Alzheimer disease, susceptibility to, PICALM-related
Alzheimer disease, susceptibility to, TOMM40-related
Alzheimer disease, susceptibility to (postulated), CELF1-related
Alzheimer disease, susceptibility to (postulated), GCAT-related
Alzheimer disease, susceptibility to (postulated), ITGAM-ITGA9-related
Alzheimer disease, susceptibility to (postulated), MAST4-related
Alzheimer disease, susceptibility to (postulated), NCSTN-related
Alzheimer disease, susceptibility to (postulated), PLD3-related
Alzheimer disease, susceptibility to (postulated), PTPRD-related
Alzheimer disease, susceptibility to (postulated), SLC2A14-related
Alzheimer disease, susceptibility to (postulated), SNRPN-related
Alzheimer disease, susceptibility to (postulated), TM2D3-related
Alzheimer disease, susceptibility to (postulated), XYLT1-related
amyloidosis, familial visceral
amyloidosis, familial visceral, LYZ-related
amyloidosis, hereditary, transthyretin-related
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis 1
amyotrophic lateral sclerosis 2, juvenile
amyotrophic lateral sclerosis 4, juvenile
amyotrophic lateral sclerosis 6 with or without frontotemporal dementia
amyotrophic lateral sclerosis 8
amyotrophic lateral sclerosis 10 with or without frontotemporal dementia
amyotrophic lateral sclerosis 11
spinocerebellar ataxia 2 (ALS13)
amyotrophic lateral sclerosis 15 with or without frontotemporal dementia
amyotrophic lateral sclerosis 16 (postulated)
amyotrophic lateral sclerosis 18
amyotrophic lateral sclerosis 20
amyotrophic lateral sclerosis 21
amyotrophic lateral sclerosis, susceptibilty to, 25
amyotrophic lateral sclerosis (postulated), EWSR1-related
amyotrophic lateral sclerosis (postulated), RAPGEF2-related
amyotrophic lateral sclerosis (postulated), SS18L1-related
frontotemporal dementia and/or amyotrophic lateral sclerosis 1
frontotemporal dementia and/or amyotrophic lateral sclerosis 2
frontotemporal dementia and/or amyotrophic lateral sclerosis 3
frontotemporal dementia and/or amyotrophic lateral sclerosis 4
frontotemporal dementia and/or amyotrophic lateral sclerosis 6
frontotemporal dementia and/or amyotrophic lateral sclerosis 7
frontotemporal dementia and/or amyotrophic lateral sclerosis, TAF15-related
anesthesia, response and mechanisms
anesthesia, response and mechanisms, PLD2-related
anesthesia, response and mechanisms, RYR-related
anesthesia, response and mechanisms, syntaxin-related
Angelman syndrome
anxiety modulators, fly wall-following model
anxiety modulator(s), serotonin class 2 receptor(s)
anxiety modulator(s), genes affecting actin filament stability
anxiety modulator(s), CCK-like receptors
ARC syndrome
arthrogryposis, renal dysfunction, and cholestasis 1
arthrogryposis, renal dysfunction, and cholestasis 2
arrhythmogenic right ventricular dysplasia 5
arthrogryposis, distal
arthrogryposis, distal, type 1, MYH3-related
arthrogryposis, distal, type 1A
arthrogryposis, distal, type 2A
arthrogryposis, distal, type 2B3
Aspergillus species infection
asthma, susceptibility to, ORMDL3-related
ataxia-telangiectasia
atrial septal defect
atrial septal defect 4
attention deficit hyperactivity disorder, susceptibility to
attention deficit hyperactivity disorder, susceptibility to (postulated), ADGRL3-related
attention deficit hyperactivity disorder, susceptibility to (postulated), FBXO25-related
attention deficit hyperactivity disorder, susceptibility to (postulated), MEF2C-related
attention deficit hyperactivity disorder, susceptibility to (postulated), SLC6A3-related
attention deficit hyperactivity disorder, susceptibility to (postulated), TRAPPC9-related
attention deficit hyperactivity disorder, susceptibility to (postulated), VPS4A-related
auditory neuropathy, autosomal dominant 1
autism co-occurence with schizophrenia
autism spectrum disorder, susceptibility to
autism, environmental risk, BPA exposure
autism spectrum disorder, susceptibility to, ASH1-related
autism spectrum disorder, susceptibility to, CHD1,2-related
autism spectrum disorder, susceptibility to, CHD6-9-related
autism spectrum disorder, susceptibility to, 18
autism spectrum disorder, susceptibility to, CSDE1-related
autism spectrum disorder, susceptibility to, de novo coding mutations (postulated)
autism spectrum disorder, susceptibility to, KDM5-related
autism spectrum disorder, susceptibility to, NBEA-related
autism spectrum disorder, susceptibility to, NLGN-related
autism spectrum disorder, susceptibility to, 20
autism spectrum disorder, susceptibility to, X-linked 1
autism spectrum disorder, susceptibility to, X-linked 2
autism spectrum disorder, susceptibility to, NRXN-related
autism spectrum disorder, susceptibility to, RIMS-related
autism spectrum disorder, susceptibility to, SHANK-related
autism spectrum disorder, susceptibility to, 17
autism spectrum disorder, susceptibility to, SLC9A6,9-related
autism spectrum disorder, susceptibility to, 16
autism spectrum disorder, susceptibility to, TSC1-related
autism spectrum disorder, susceptibility to, UBE3A-related
autism spectrum disorder, susceptibility to, WDFY3,4-related
autism spectrum disorder, susceptibility to (postulated), ABCA-related
autism spectrum disorder, susceptibility to (postulated), MAPK3-related
autism spectrum disorder, susceptibility to (postulated), NDST-related
autism spectrum disorder, susceptibility to (postulated), SLC6A3-related
autism spectrum disorder, susceptibility to (postulated), TAOK2-related
autism spectrum disorder, susceptibility to (postulated), TOP3B-related
autism spectrum disorder, susceptibility to (postulated), TRPC6-related
autism spectrum disorder with intellectual disability and seizures (postulated), SCAMP5-related
White-Sutton syndrome
azoospermia, non-obstructive
azoospermia, Sertoli-cell-only syndrome, DDX3-related
azoospermia (postulated), CDC42BPA-related
azoospermia (postulated), DMRT2-related
azoospermia (postulated), ESRRB-ESRRG-related
azoospermia (postulated), NDST1-related
azoospermia (postulated), PTPRD-related
azoospermia (postulated), SNRPA1-related
azoospermia (postulated), TDRKH-related
azoospermia (postulated), TEX10-related
azoospermia (postulated), TEX13A-related
azoospermia (postulated), YIPF5-related
azoospermia (postulated), ZFAND3-related
azoospermia (postulated), ZNF622-related
azoospermia and testicular cancer (postulated), RBBP7-related
azoospermia and testicular germ cell cancer (postulated), FOXN3-related
azoospermia associated with Bardet-Biedl syndrome, SCAPER-related
Barth syndrome
basal cell carcinoma, SMO-related
Becker muscular dystrophy
Birt-Hogg-Dube syndrome
Bloom syndrome
Boucher-Neuhauser syndrome
brachycephaly, trichomegaly, and developmental delay
branchiootorenal spectrum disorders, EYA1-related
branchiootorenal syndrome 1
branchiootic syndrome 1
Brown-Vialetto-Van Laere syndrome 1
Brown-Vialetto-Van Laere syndrome 2
calcium-induced neurotoxicity, TRP-channel-related
cancer, general (fly models overview)
acute myeloid leukemia
acute myeloid leukemia, MLF1-related
acute myeloid leukemia, MLL-AF fusions
acute myeloid leukemia, NUP98-HOXA9 fusion
acute myeloid leukemia, RUNX1-RUNX1T1 fusion
acute myeloid leukemia models, RAS-Scrib-complex-related
adenoid cystic carcinoma, multigenic, personalized
azoospermia and testicular germ cell cancer (postulated), FOXN3-related
basal cell carcinoma, SMO-related
cachexia, IGFBP-related
cachexia, RAS-SCRIB larval model
cachexia, yki-induced eye tumor model
cachexia, yki-induced ISC tumor model
cancer, aerobic glycolysis (Warburg effect), larval growth model
cancer, epithelial, ABL-related
cancer, epithelial, AFDN-SCRIB-related
cancer, epithelial, ALG3-related
cancer, epithelial, compromised apoptosis
cancer, epithelial, compromised apoptosis and cell-cycle checkpoint defects
cancer, epithelial, compromised apoptosis and DNA repair defects
cancer, epithelial, DLG1-related
cancer, epithelial, DST-related
cancer, epithelial, EGFR-related
cancer, epithelial, EGFR-Dmel_psq model
cancer, epithelial, EGFR-Hippo-signaling
cancer, epithelial, EGFR-HSPG2 related
cancer, epithelial, EGFR-microRNA-related
cancer, epithelial, EGFR-SOCS-related
cancer, epithelial, ESCRT-complexes-related
cancer, epithelial, glycolytic tumor model
cancer, epithelial, ING1-related
cancer, epithelial, LLGL-related
cancer, epithelial, LLGL-MYC-related
cancer, epithelial, LLGL-YAP1-related
cancer, epithelial, Notch signaling, Hedgehog signaling
basal cell carcinoma, SMO-related
cancer, epithelial, NOTCH-LLGL-related
cancer, epithelial, NOTCH-SCRIB-related
cancer, epithelial, Par-complex-related
cancer, epithelial, RAB5-microRNA-related
cancer, epithelial, RAF-Hippo-signaling
cancer, epithelial, RAF-SCRIB-related
cancer, epithelial, RAS models, role of autophagy
cancer, epithelial, RAS-ATP6V-related
cancer, epithelial, RAS-DLG1-related
cancer, epithelial, RAS-Hippo-signaling
cancer, epithelial, RAS-LLGL-related
cancer, epithelial, RAS-PAXIP1/TP53-related
cancer, epithelial, RAS-SCRIB-related
cancer, epithelial, RAS-STK11-related
cancer, epithelial, RAS-TSPAN-related
cancer, epithelial, RPS6KA3-related
cancer, epithelial, SALL4-related
cancer, epithelial, SCRIB-hyperinsulinemia model
cancer, epithelial, SCRIB-LATS1,2-related
cancer, epithelial, SCRIB-MAPK1,3-related
cancer, epithelial, SCRIB-related
cancer, epithelial, SCRIB-YAP1-related
cancer, epithelial, SCRIB-ZBTB(TF)-related
cancer, epithelial, Scribble-complex-related
cancer, epithelial, SRC,CSK-related
cancer, epithelial, STAG1,2-related
cancer, epithelial, STX7,12-related
cancer, epithelial, TNF-DLG1-related
cancer, epithelial, TNF-SCRIB-related
cancer, epithelial, TNF-SCRIB-RAS-related
cancer, epithelial, Toll-receptor-related
cancer, gastrointestinal, susceptibility due to H. pylori infection
cancer, germline stem cell models
cancer, inherited susceptibilities to
Cowden syndrome 1
familial adenomatous polyposis
familial adenomatous polyposis 1
gastric cancer, hereditary diffuse, CDH1-related
juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
Li-Fraumeni syndrome 1
multiple endocrine neoplasia
multiple endocrine neoplasia, type I
multiple endocrine neoplasia, type IIA
multiple endocrine neoplasia, type IIB
neuroblastoma, susceptibility to, 3
pituitary adenoma 1, multiple types
rhabdoid tumor predisposition syndrome 1
schwannomatosis, vestibular
von Hippel-Lindau syndrome
cancer, intercellular interactions, RAS-mito
cancer, intercellular interactions, RAB5-related
cancer, epithelial, RAB5-microRNA-related
cancer, intercellular interactions, SRC-related
cancer, intestinal dysplasia, UVRAG-related
cancer, intestinal stem cell models
cancer, intestinal stem cell, APC-RAS-related
cancer, intestinal stem cell, APC-RAS-SNA-related
cancer, intestinal stem cell, EGFR-related
cancer, intestinal stem cell, NOTCH-related
cancer, intestinal stem cell, RAS-NOTCH-related
cancer, intestinal stem cell, RAS-related
cancer, intestinal stem cell (postulated), SNX9,18,33-related
cancer, intestinal stem cell, SRC-related
cancer, ISC, intercellular feedback loop, SOX-related
cancer, intestinal, impact of Pseudomonas aeruginosa infection
cancer, invasive collective cell migration, border cell model
cancer, malignant glioma, AURKA/WDR62-related
cancer, malignant glioma, EGFR-related
cancer, malignant glioma, EGFR-MYC-related
cancer, malignant glioma, EGFR-PIK3C-related
cancer, malignant glioma, FGFR-TACC fusion
cancer, malignant glioma, H3-3A-related
cancer, malignant glioma, Par-complex-related
cancer, malignant glioma, RAS model
cancer, malignant glioma, RAS-PTEN-related
cancer, Malpighian tubule stem cell
cancer, mesothelial, FMR1-related
cancer, models of chromosomal instability
cancer, multiple, actin-remodeling regulators
cancer, multiple, ALK-related
cancer, multiple, apoptosis-induced proliferation
cancer, multiple, AXIN-related
cancer, multiple, BRAF-related
cancer, multiple, CCR4-NOT complex
cancer, multiple, CTNNB1-related
cancer, multiple, epigenetic mechanisms
cancer, multiple, germline-specific genes
cancer, multiple, HIPK-related
cancer, multiple, Hippo signaling pathway
cancer, multiple, IDH1,2-related
cancer, multiple, JAG-microRNA-related
cancer, multiple, MAP2K1,2-related
cancer, multiple, MAPK1,3-related
cancer, multiple, MYC-related
cancer, multiple, modulation by steroid hormone via mir-let7
cancer, multiple, NEK2-RAS-CSK(SRC)-related
cancer, multiple, NEK2-RET-related
cancer, multiple, Notch signaling pathway
cancer, multiple, NOTCH-MEF2-related
cancer, multiple, NOTCH-PI3K-AKT-related
cancer, multiple, NOTCH-SRC-related
cancer, multiple, PI3K-AKT signaling pathway
cancer, multiple, RAF-RHOGEF-related
cancer, multiple, RAF1-related
cancer, multiple, RAS with actin regulators
cancer, multiple, RAS-related
cancer, multiple, RAS-CSK(SRC)-related
cancer, multiple, RAS-CSK(SRC)-related with high-sugar diet
cancer, multiple, RAS-RHOGEF-related
cancer, multiple, RAS-S100A4-related
cancer, multiple, RAS-SRC-related
cancer, multiple, RAS-Vps-C complex-related
cancer, multiple, regulators of necrosis
cancer, multiple, RET fusions
lung cancer, adenocarcinoma, KIF5B-RET fusion
thyroid carcinoma, nonmedullary, CCDC6-RET fusion
thyroid carcinoma, nonmedullary, NCOA4-RET fusion
cancer, multiple, TET2-related
cancer, multiple, TP53-related
cancer, multiple, UBIAD1-related
cancer, multiple, WWOX-related
cancer, neural stem cell, AFDN-SCRIB-related
cancer, neural stem cell, centrosome dysfunction
cancer, neural stem cell, disruption of asymmetric division
cancer, neural stem cell, HES (bHLH TF)-related
cancer, neural stem cell, LLGL-related
cancer, neural stem cell, L3MBTL-related
cancer, neural stem cell, Notch-related
cancer, neural stem cell, NR2E1-related
cancer, neural stem cell, retromer tumor suppressors
cancer, neural stem cell, TRIM2,3-related
cancer, neural stem cell dedifferentiation
cancer, sarcoma, CIC-DUX4 fusion
cancer, tracheal model of angiogenesis
cancer therapeutic, Drosophila deoxyribonucleoside kinase
colorectal cancer
cancer, intestinal dysplasia, UVRAG-related
cancer, intestinal stem cell, SRC-related
colorectal cancer, multigenic
colorectal cancer, multigenic, personalized
colorectal cancer, personalizable in silico model
familial adenomatous polyposis
Ewing sarcoma
familial adenomatous polyposis
familial adenomatous polyposis 1
gastric cancer, hereditary diffuse, CDH1-related
gastric cancer, TPM4-ALK fusion
hematologic cancer (fly models overview)
acute myeloid leukemia
acute myeloid leukemia, MLF1-related
acute myeloid leukemia, MLL-AF fusions
acute myeloid leukemia, NUP98-HOXA9 fusion
acute myeloid leukemia, RUNX1-RUNX1T1 fusion
acute myeloid leukemia models, RAS-Scrib-complex-related
chronic myeloid leukemia, BCR-ABL1 fusions
hematologic cancer, compromised sumoylation
hematologic cancer, CUX-related
hematologic cancer, Dmel_mxc model
HTLV-1-induced adult T-cell leukemia/lymphoma
juvenile myelomonocytic leukemia
juvenile myelomonocytic leukemia, PTPN11-related
myeloproliferative disorders, JAK2-related
HPV-related carcinoma, E5-E6-E7-UBE3A models
juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
Li-Fraumeni syndrome 1
lung cancer, adenocarcinoma, KIF5B-RET fusion
lung cancer, RAS-PTEN-related
multiple endocrine neoplasia
multiple endocrine neoplasia, type I
multiple endocrine neoplasia, type IIA
multiple endocrine neoplasia, type IIB
multiple myeloma, DIS3-related
myeloproliferative disorders, JAK2-related
neuroblastoma, susceptibility to, 3
pancreatic carcinoma, multigenic
pituitary adenoma 1, multiple types
prostate cancer
prostate cancer, E-cadherin-related
prostate cancer, N-cadherin-related
prostate cancer, PAX-related
prostate cancer model, Drosophila cell culture exposed to synthetic androgen
prostate cancer (postulated), astacin-related
prostate cancer (postulated), CNPY1,2-related
prostate cancer (postulated), MRGBP-related
rhabdoid tumor predisposition syndrome 1
rhabdomyosarcoma 2, PAX7-FOXO1 fusion
rhabdomyosarcoma 2, PAX3-FOXO1 fusion
schwannomatosis, vestibular
thyroid carcinoma, familial medullary
multiple endocrine neoplasia
thyroid carcinoma, nonmedullary
von Hippel-Lindau syndrome
Candida species infection
cardiac dysfunction (fly models overview)
cardiac arrhythmias
cardiac arrhythmias and seizure sensitivity, KCNH-related
long QT syndrome 2
cardiac arrhythmias, KCNQ-related
long QT syndrome 1
cardiac arrhythmia modeled by tachypacing
cardiac arrhythmia (postulated), ATP2A-related
cardiac arrhythmia (postulated), CAMK2-related
cardiac arrhythmia (postulated), ETNK-related
cardiac arrhythmia (postulated), KCNK-related
cardiac arrhythmia (postulated), KCNMA1-related
long QT syndrome
long QT syndrome 1
long QT syndrome 2
cardiac dysfunction, COX-2 inhibitor-induced
cardiac dysfunction, tumor-induced
cardiac dysfunction (postulated), CCR4-NOT complex
cardiac dysfunction (postulated), CRLS1-related
cardiac dysfunction (postulated), PYGO-related
cardiac dysfunction (postulated), SOX5-related
cardiac dysfunction (postulated), SPARC-related
cardiac dysfunction (postulated), talin-related
cardiac dysfunction (postulated), TRiC/CCT complex
cardiomyopathy
arrhythmogenic right ventricular dysplasia 5
cardiomyopathy, familial hypertrophic
cardiomyopathy, familial hypertrophic 1
cardiomyopathy, familial hypertrophic 2
cardiomyopathy, familial hypertrophic 3
cardiomyopathy, familial hypertrophic 4
cardiomyopathy, familial hypertrophic 7
cardiomyopathy, familial hypertrophic 10
cardiomyopathy, familial hypertrophic 11
cardiomyopathy, familial hypertrophic 14
cardiomyopathy, familial hypertrophic 15
cardiomyopathy, familial hypertrophic 17
cardiomyopathy, familial hypertrophic 18
cardiomyopathy, familial hypertrophic 26
cardiomyopathy, hypertrophic (postulated), EGFR/ERBB-related
cardiomyopathy, hypertrophic (postulated), profilin-related
cardiomyopathy, hypertrophic (postulated), RAF-related
cardiomyopathy, hypertrophic (postulated), RAS-related
cardiomyopathy, familial restrictive
cardiomyopathy, familial restrictive 1
cardiomyopathy, familial restrictive 3
cardiomyopathy induced by nephrocyte loss/dysfunction
cardiomyopathy, MYBPC3-related
cardiomyopathy, familial hypertrophic 4
dilated cardiomyopathy 1MM
cardiomyopathy, MYH6-MYH7-related
cardiomyopathy, familial hypertrophic 1
cardiomyopathy, familial hypertrophic 14
dilated cardiomyopathy 1EE
dilated cardiomyopathy 1S
cardiomyopathy, PLN-related
cardiomyopathy, familial hypertrophic 18
dilated cardiomyopathy 1P
cardiomyopathy (postulated), calcineurin-A-related
cardiomyopathy (postulated), SOCE-related
cardiomyopathy (postulated), translation-critical genes
cardiomyopathy, TNNI3-related
cardiomyopathy, familial hypertrophic 7
cardiomyopathy, familial restrictive 1
dilated cardiomyopathy 1FF
dilated cardiomyopathy 2A
cardiomyopathy, TNNT2-related
cardiomyopathy, familial hypertrophic 2
cardiomyopathy, familial restrictive 3
dilated cardiomyopathy 1D
cardiomyopathy, TPM1-related
cardiomyopathy, familial hypertrophic 3
cardiomyopathy, VCL-related
cardiomyopathy, familial hypertrophic 15
dilated cardiomyopathy 1W
dilated cardiomyopathy
dilated cardiomyopathy 1A
dilated cardiomyopathy 1D
dilated cardiomyopathy 1EE
dilated cardiomyopathy 1FF
dilated cardiomyopathy 1L
dilated cardiomyopathy 1MM
dilated cardiomyopathy 1NN
dilated cardiomyopathy 1P
dilated cardiomyopathy 1S
dilated cardiomyopathy 1U
dilated cardiomyopathy 1V
dilated cardiomyopathy 1W
dilated cardiomyopathy 1Y
dilated cardiomyopathy 2A
dilated cardiomyopathy 2C
dilated cardiomyopathy 3B
dilated cardiomyopathy, Notch signaling
dilated cardiomyopathy, presenilin-related
dilated cardiomyopathy (postulated), CNOT3-related
dilated cardiomyopathy (postulated), rhomboid-EGFR signaling
high-fat diet, cardiomyopathy
high-sugar diet, cardiomyopathy
lipotoxic cardiomyopathy, ceramide/sphingolipid-related
muscle and aortic defects, ARIH1-related
cardiac function, response to hypoxia
cardiofaciocutaneous syndrome
cardiofaciocutaneous syndrome 3
cardiofaciocutaneous syndrome 4
cataract 48, infantile-onset
CEDNIK syndrome
centronuclear myopathy
centronuclear myopathy 1
centronuclear myopathy 2
centronuclear myopathy, X-linked
cerebellar atrophy, visual impairment, and psychomotor retardation
cerebral amyloid angiopathy
cerebral amyloid angiopathy, APP-related
cerebral amyloid angiopathy, ITM2B-related
cerebral amyloid angiopathy, ITM2B-related, 1
cerebral amyloid angiopathy, ITM2B-related, 2
cerebral cavernous malformations 3
cerebral palsy, spastic quadriplegic
cerebral palsy, spastic quadriplegic, 3
Charcot-Marie-Tooth disease
Charcot-Marie-Tooth disease, axonal, type 2EE
Charcot-Marie-Tooth disease, axonal, type 2L
Charcot-Marie-Tooth disease, dominant intermediate B
Charcot-Marie-Tooth disease, dominant intermediate C
Charcot-Marie-Tooth disease, dominant intermediate E
Charcot-Marie-Tooth disease, GDAP1-related
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis
Charcot-Marie-Tooth disease, recessive intermediate A
Charcot-Marie-Tooth disease, type 2K
Charcot-Marie-Tooth disease, type 4A
Charcot-Marie-Tooth disease, MFN2-related
Charcot-Marie-Tooth disease, axonal, type 2A2A
Charcot-Marie-Tooth disease, axonal, type 2A2B
neuropathy, hereditary motor and sensory, type VIA
Charcot-Marie-Tooth disease, RAB40B-related
Charcot-Marie-Tooth disease, recessive intermediate D
Charcot-Marie-Tooth disease, type 2B
Charcot-Marie-Tooth disease, type 2D
Charcot-Marie-Tooth disease, type 2T
Charcot-Marie-Tooth disease, type 4B1
Charcot-Marie-Tooth disease, type 4J
Charcot-Marie-Tooth disease (postulated), SGPL1-related
neuropathy, hereditary motor and sensory, type IIC
CHARGE syndrome, CHD7-related
Chediak-Higashi syndrome
chorea-acanthocytosis
chromosome 3q29 deletion syndrome
chromosome 15q11.2 deletion syndrome
chromosome 16p11.2 deletion syndrome, 593-kb
chromosome 22q11.2 deletion syndrome
chronic inflammatory lung disease
chronic myeloid leukemia, BCR-ABL1 fusions
ciliary dyskinesia, primary
ciliary dyskinesia, primary, 9, with or without situs inversus
ciliary dyskinesia, primary, 18
ciliary dyskinesia, primary, 22
CODAS syndrome
coenzyme Q10 deficiency, primary
coenzyme Q10 deficiency, primary, 4
nephrotic syndrome related to coenzyme Q deficiency
Coffin-Lowry syndrome
Coffin-Siris syndrome
Coffin-Siris syndrome, ARID1A,1B-related
Coffin-Siris syndrome 1
Coffin-Siris syndrome 2
Coffin-Siris syndrome 3
Coffin-Siris syndrome 4
Coffin-Siris syndrome 8
Coffin-Siris syndrome 11
Coffin-Siris syndrome 12
Coffin-Siris syndrome (postulated), PHF10-related
cognitive/behavioral disorders, PRODH-related
cognitive disorders, diet-induced
cognitive impairment, drug-induced
colorectal cancer
cancer, intestinal dysplasia, UVRAG-related
cancer, intestinal stem cell, SRC-related
colorectal cancer, multigenic
colorectal cancer, multigenic, personalized
colorectal cancer, personalizable in silico model
familial adenomatous polyposis
combined D-2- and L-2-hydroxyglutaric aciduria
combined oxidative phosphorylation deficiency
combined oxidative phosphorylation deficiency 1
combined oxidative phosphorylation deficiency 14
combined oxidative phosphorylation deficiency 17
combined oxidative phosphorylation deficiency 28
combined oxidative phosphorylation deficiency 30
combined oxidative phosphorylation deficiency 54
cone-rod dystrophy
cone-rod dystrophy 2
cone-rod dystrophy 12
congenital disorders of glycosylation, type I
congenital disorder of glycosylation, type Ia
congenital disorder of glycosylation, type Ij
congenital disorders of glycosylation, type II
congenital disorder of glycosylation, type IIc
congenital disorder of glycosylation, type IIe
congenital disorder of glycosylation, type IIr
congenital heart defect
atrial septal defect
atrial septal defect 4
congenital heart defect (postulated), CHD7-related
congenital heart defect (postulated), EIF4G3-related
congenital heart defect (postulated), KMT2-related
congenital heart defect (postulated), LRP2-related
congenital heart defect (postulated), METTL23-related
congenital heart defect (postulated), PSMD7-related
congenital heart defect (postulated), RPL13-related
congenital heart defect (postulated), RPL14-related
congenital heart defect (postulated), RPS24-related
congenital heart defect (postulated), SREBF1-related
congenital heart defect (postulated), UBB-related
congenital heart defect (postulated), UBE2B-related
congenital heart defect (postulated), WDR5-related
congenital heart defect (postulated), KIF1A-related
hypoplastic left heart syndrome (postulated), CHCHD3,6-related
congenital myasthenic syndrome
congenital myasthenic syndrome 7, presynaptic
copper metabolism disorders, ATP7-related
Menkes disease
neuronopathy, distal hereditary motor, X-linked
occipital horn syndrome
Wilson disease
copper metabolism disorder (postulated), SLC31A-related
Cornelia de Lange syndrome
Cornelia de Lange syndrome 1
Costello syndrome
Cowden syndrome 1
Creutzfeldt-Jakob disease, familial
cystic fibrosis, gastrointestinal pathologies
cystic fibrosis-like, miRNA-mediated ENaC dysregulation
cystic renal dysplasia, susceptibility to, BICC1-related
D-2-hydroxyglutaric aciduria
D-2-hydroxyglutaric aciduria 2
combined D-2- and L-2-hydroxyglutaric aciduria
Darier-White disease
deafness and hearing loss (fly models overview)
auditory neuropathy, autosomal dominant 1
branchiootorenal spectrum disorders, EYA1-related
branchiootic syndrome 1
ciliary dyskinesia, primary
deafness, autosomal dominant
deafness, autosomal dominant 11
deafness, autosomal recessive
deafness, autosomal recessive 2
deafness, autosomal recessive 36
deafness, autosomal recessive 67
deafness, autosomal recessive 114
DOORS syndrome
mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
noise-induced hearing loss
Siddiqi syndrome
Usher syndrome
Usher syndrome, type I
Usher syndrome, type IJ
Usher syndrome, deafness, MYO7A-related
dentatorubral-pallidoluysian atrophy
depression-like behaviors, drug-induced
depression-like behaviors, stress-induced
depression-like behaviors (postulated), MIR184-related
DeSanto-Shinawi syndrome
developmental and epileptic encephalopathy
developmental and epileptic encephalopathy 6
developmental and epileptic encephalopathy 11
developmental and epileptic encephalopathy 13
developmental and epileptic encephalopathy 14
developmental and epileptic encephalopathy 17
developmental and epileptic encephalopathy 25, with amelogenesis imperfecta
developmental and epileptic encephalopathy 34
developmental and epileptic encephalopathy 44
developmental and epileptic encephalopathy 47
developmental and epileptic encephalopathy 57
developmental and epileptic encephalopathy 64
developmental and epileptic encephalopathy 87
developmental and epileptic encephalopathy 96
developmental and epileptic encephalopathy 109
developmental and epileptic encephalopathy (postulated), ROBO1-related
developmental and epileptic encephalopathy (postulated), TMEM63B-related
developmental delay and seizures, FARS2-related
combined oxidative phosphorylation deficiency 14
spastic paraplegia 77
developmental delay, dysmorphic facies, and brain anomalies
diabetes mellitus, insulin-dependent (type 1) (fly models overview)
diabetes mellitus type 1, environmental toxin-induced
diabetes mellitus type 1, insulin peptide deficiency
diabetes mellitus, insulin-dependent, IPC-ablation models
diabetes mellitus, insulin-dependent, IPC-blocking model
diabetes mellitus, permanent neonatal 4
obesity and diabetes type 1, susceptibility to (postulated), ITPR-related
diabetes mellitus, insulin-resistant, with acanthosis nigricans
diabetes mellitus, noninsulin-dependent (type 2) (fly models overview)
diabetes mellitus type 2, environmental toxin-induced
diabetes mellitus type 2, susceptibility to, AKT-related
diabetes mellitus type 2, susceptibility to, HHEX-related
diabetes mellitus type 2, susceptibility to, IGF2BP-related
diabetes mellitus type 2, susceptibility to, IRS1,2-related
diabetes mellitus type 2, susceptibility to (postulated), AFF2-related
diabetes mellitus type 2, susceptibility to (postulated), BCL11A-related
diabetes mellitus type 2, susceptibility to (postulated), GLIS3-related
diabetes mellitus type 2, susceptibility to (postulated), UCHL1-related
diabetes/obesity, impact of parental disease
glucose metabolism disease, GCK-related
maturity-onset diabetes of the young, type 2
high-fat diet, insulin pathway effects
high-protein diet, insulin pathway effects
high-sugar diet, adipokinetic hormone signaling
high-sugar diet, insulin pathway effects
insulin pathway effects, BMP/TGFB-related
insulin pathway effects, decretin-related
insulin pathway effects, DGK-related
insulin pathway effects, FMR1-related
insulin pathway effects, IDE-related
insulin pathway effects, mechanical stress requirement
insulin pathway effects, MIR137/PTPN1,2-related
insulin pathway effects, MYORG-related
insulin pathway effects, NUDT-related
insulin pathway effects, PIK3C-related
insulin pathway effects, RHEB-related
insulin pathway effects, RPS6KB-related
insulin pathway effects, SIRT1-related
insulin pathway effects, TMEM18-related
insulin pathway effects, TRIB-related
insulin resistance syndromes, INSR-related
diabetes mellitus, insulin-resistant, with acanthosis nigricans
Donohue syndrome
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
insulin signaling, regulation of fat storage, Drosophila fat body model
maturity-onset diabetes of the young, type 1
diabetes mellitus, pathogenic impact, glyoxalase function
diabetes/obesity, impact of parental disease
diabetic neuropathy
Donohue syndrome
DOORS syndrome
Down syndrome
Down syndrome, DSCAM-related
Down syndrome, DYRK1A-related
Down syndrome, ITSN1-SYNJ1-RCAN1-related
Down syndrome, RCAN1-related
Down syndrome heart defects, DSCAM-COL6A2-related
drug discovery and assessment (fly models overview)
Duchenne muscular dystrophy
DYRK1A-related intellectual disability syndrome
dyskeratosis congenita
dyskeratosis congenita, X-linked
dyskinesia, drug-induced
dystonia
dystonia 1
dystonia, early-onset, and/or spastic paraplegia
MEPAN syndrome
Ehlers-Danlos syndrome
Ehlers-Danlos syndrome, spondylodysplastic type 1
Ehlers-Danlos syndrome, spondylodysplastic type 3
encephalopathy due to defective mitochondrial and peroxisomal fission 1
encephalopathy, familial, with neuroserpin inclusion bodies
encephalopathy, hypotonia and developmental delay, OXA1L-related
encephalopathy, neonatal severe, MECP2-related
encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum
epidermolysis bullosa simplex, keratin-related
epidermolysis bullosa simplex, localized
epidermolysis bullosa simplex, generalized
epidermolysis bullosa simplex, generalized severe
epilepsy
developmental and epileptic encephalopathy
developmental and epileptic encephalopathy 6
developmental and epileptic encephalopathy 11
developmental and epileptic encephalopathy 13
developmental and epileptic encephalopathy 14
developmental and epileptic encephalopathy 25, with amelogenesis imperfecta
developmental and epileptic encephalopathy 34
developmental and epileptic encephalopathy 57
developmental and epileptic encephalopathy 64
developmental and epileptic encephalopathy 87
developmental and epileptic encephalopathy 96
epilepsy, chemically-induced
epilepsy, early-onset
epilepsy, early-onset, 3, with or without developmental delay
epilepsy, familial adult myoclonic
epilepsy, familial adult myoclonic, 4
epilepsy, focal (postulated), UNC13B-related
epilepsy, generalized, with febrile seizures plus
epilepsy, generalized, with febrile seizures plus, type 2
epilepsy, generalized, with febrile seizures plus, type 7
epilepsy, nocturnal frontal lobe, 5
epilepsy, photosensitive, sphingolipid/sphingomyelin-related
epilepsy, PRICKLE-related
epilepsy, progressive myoclonic 1B
epilepsy, progressive myoclonic
epilepsy, progressive myoclonic 1B
epilepsy, progressive myoclonic 6
epilepsy, refractory, SCN-alpha-ABCC1 model
epilepsy, rolandic, with paroxysmal exercise-induced dystonia
epilepsy, SCN-alpha-related
developmental and epileptic encephalopathy, 6
developmental and epileptic encephalopathy, 11
developmental and epileptic encephalopathy, 13
epilepsy, generalized, with febrile seizures plus, type 2
epilepsy, generalized, with febrile seizures plus, type 7
seizures, benign familial infantile, 3
epilepsy, SLC12A5-related
developmental and epileptic encephalopathy, 34
epilepsy, idiopathic generalized, susceptibility to, 14
Kohlschutter-Tonz syndrome
mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
myoclonic-atonic epilepsy
seizures, benign familial infantile
seizures, benign familial infantile, 3
seizure-sensitive (postulated), ETNK-related
seizure-sensitive (postulated), SLC12A1-3-related
seizure-sensitive (postulated), SLC24A-related
seizure-sensitive, potassium channel defects (eag, Sh model)
seizure-sensitive, potassium channel defects, KCNT1-2-related
developmental and epileptic encephalopathy 14
developmental and epileptic encephalopathy 57
epilepsy, nocturnal frontal lobe, 5
seizure sensitive/resistant (postulated), PRKG1-related
seizure sensitivity, disruption during critical developmental period
seizure-sensitivity model, Dmel_jus
episodic ataxia
episodic ataxia, type 1
episodic ataxia, type 6
Epstein-Barr virus infection
erythrokeratodermia variabilis et progressiva 1
Escherichia coli infection
essential tremor, hereditary
essential tremor, hereditary, 4
essential tremor (postulated), KCNS2-related
Ewing sarcoma
Fabry disease
familial adenomatous polyposis
familial adenomatous polyposis 1
Fanconi anemia
Fanconi anemia, complementation group D2
Fanconi anemia, complementation group L
Fanconi renotubular syndrome 4 with MODY
fascioscapulohumeral muscular dystrophy, DUX4-related
fascioscapulohumeral muscular dystrophy, FRG1-related
fatal familial insomnia
fibrodysplasia ossificans progressiva
fibrosis, pericellular accumulation of collagen IV
flavivirus infection (dengue, West Nile, Zika)
Fliedner-Zweier syndrome
focal segmental glomerulosclerosis
focal segmental glomerulosclerosis 1
focal segmental glomerulosclerosis 3
focal segmental glomerulosclerosis 4, susceptibility to
focal segmental glomerulosclerosis 5
fragile-X-related syndromes
fragile X syndrome
fragile X tremor/ataxia syndrome
Friedreich ataxia 1
frontotemporal dementia
frontotemporal dementia with parkinsonism 17
frontotemporal dementia and/or amyotrophic lateral sclerosis 1
frontotemporal dementia and/or amyotrophic lateral sclerosis 2
frontotemporal dementia and/or amyotrophic lateral sclerosis 3
frontotemporal dementia and/or amyotrophic lateral sclerosis 4
frontotemporal dementia and/or amyotrophic lateral sclerosis 6
frontotemporal dementia and/or amyotrophic lateral sclerosis 7
frontotemporal dementia and/or amyotrophic lateral sclerosis, TAF15-related
galactosemia
galactose epimerase deficiency
galactosemia, classic
Galloway-Mowat syndrome 3
GAND syndrome
gastric cancer, hereditary diffuse, CDH1-related
gastric cancer, TPM4-ALK fusion
Gaucher disease, GBA1-related
genotoxicity studies (fly models overview)
geroderma osteodysplastica
Gerstmann-Straussler disease
glaucoma
glaucoma 1A, open angle, early-onset
glaucoma 1E, primary open angle
global developmental delay and congenital ataxia, CACNA1A-related
global developmental delay with impaired intellectual development, hypotonia, and seizures, CAPZA2-related
glucose metabolism disease, GCK-related
maturity-onset diabetes of the young, type 2
glycerol kinase deficiency
glycogen accumulation disorders, GYS1 model
glycogen storage disease III
Harel-Yoon syndrome
Halperin-Birk syndrome
hematologic cancer (fly models overview)
acute myeloid leukemia
acute myeloid leukemia, MLF1-related
acute myeloid leukemia, MLL-AF fusions
acute myeloid leukemia, NUP98-HOXA9 fusion
acute myeloid leukemia, RUNX1-RUNX1T1 fusion
acute myeloid leukemia models, RAS-Scrib-complex-related
chronic myeloid leukemia, BCR-ABL1 fusions
hematologic cancer, compromised sumoylation
hematologic cancer, CUX-related
hematologic cancer, Dmel_mxc model
HTLV-1-induced adult T-cell leukemia/lymphoma
juvenile myelomonocytic leukemia
juvenile myelomonocytic leukemia, PTPN11-related
myeloproliferative disorders, JAK2-related
Hengel-Maroofian-Schols syndrome
Hennekam lymphangiectasia-lymphedema syndrome 2
Hermansky-Pudlak syndrome
Hermansky-Pudlak syndrome 2
Hermansky-Pudlak syndrome 4
Hermansky-Pudlak syndrome 5
Hermansky-Pudlak syndrome 7
Hermansky-Pudlak syndrome 9
Hermansky-Pudlak syndrome (postulated), BLOC1S1-related
high-fat diet, cardiomyopathy
high-fat diet, insulin pathway effects
high-fat diet, kidney disease
high-fat diet, obesity
high-protein diet, insulin pathway effects
high-salt diet, locomotor and cardiac dysfunction
high-starch diet, obesity
high-sugar diet, adipokinetic hormone signaling
high-sugar diet, cardiomyopathy
high-sugar diet, insulin pathway effects
high-sugar diet, nephropathy
high-sugar diet, obesity
high-sugar diet, retinopathy
Hirschsprung disease, susceptibility to, 1
histiocytosis-lymphadenopathy plus syndrome
HIV infection
homocystinuria due to cystathionine beta-synthase deficiency
HPV-related carcinoma, E5-E6-E7-UBE3A models
HSD10 mitochondrial disease
HTLV-1-induced adult T-cell leukemia/lymphoma
Huntington disease
Huntington disease-like 2
Hutchinson-Gilford progeria syndrome
hydrolethalus syndrome 1
hyperoxaluria, primary
hyperoxaluria, primary, type 1
hyperprolinemia, type II
hypoparathyroidism, familial isolated, GCM2-related
hypoparathyroidism-retardation-dysmorphism syndrome
hypoplastic left heart syndrome (postulated), CHCHD3,6-related
hypotonia, ataxia, and delayed development syndrome
hypoxia adaptation and chronic mountain sickness
ichthyosis, Dmel_osy model
IMAGe syndrome
immune and hematological syndromes, CDC42-related
inclusion body myopathy with Paget disease of bone and frontotemporal dementia
inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
inclusion body myopathy with or without frontotemporal dementia (postulated), SVIP-related
infantile cerebellar-retinal degeneration
infection by eukaryotic pathogens
Aspergillus species infection
Candida species infection
Leishmania species infection
infection by prokaryotic pathogens
Escherichia coli infection
Listeria monocytogenes infection
Mycobacterium species infection
Pseudomonas aeruginosa infection
Salmonella species infection
Serratia marcescens infection
Staphylococcus aureus infection
Streptococcus species infection
Vibrio cholerae infection
infection by viral pathogens
Epstein-Barr virus infection
flavivirus infection (dengue, West Nile, Zika)
HIV infection
SARS-CoV-1,2 viral infection
Sindbis virus infection
viral infection, susceptibility to (postulated), EHMT-related
inflammatory bowel disease
inflammatory bowel disease 10, susceptibility to
inflammatory bowel disease, tight/septate junction defect
insulin pathway effects, BMP/TGFB-related
insulin pathway effects, decretin-related
insulin pathway effects, FMR1-related
insulin pathway effects, IDE-related
insulin pathway effects, MIR137/PTPN1,2-related
insulin pathway effects, MYORG-related
insulin pathway effects, NUDT-related
insulin pathway effects, PIK3C-related
insulin pathway effects, RHEB-related
insulin pathway effects, RPS6KB-related
insulin pathway effects, SIRT1-related
insulin pathway effects, TMEM18-related
insulin pathway effects, TRIB-related
insulin resistance syndromes, INSR-related
diabetes mellitus, insulin-resistant, with acanthosis nigricans
Donohue syndrome
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
intellectual developmental disorder with abnormal behavior, microcephaly, and short stature
intellectual developmental disorder with ocular anomalies and distinctive facial features
intellectual developmental disorder with short stature and behavioral abnormalities, IQSEC1-related
intellectual developmental disorder, X-linked, syndromic, Pilorge type
intellectual developmental disorders, SMARCA2,4-related
Coffin-Siris syndrome 4
Nicolaides-Baraitser syndrome
intellectual disability, autosomal dominant
Coffin-Siris syndrome
Coffin-Siris syndrome, ARID1A,1B-related
Coffin-Siris syndrome 1
Coffin-Siris syndrome 2
Coffin-Siris syndrome 3
Coffin-Siris syndrome 4
Coffin-Siris syndrome 8
Coffin-Siris syndrome 11
Coffin-Siris syndrome 12
Coffin-Siris syndrome (postulated), PHF10-related
DYRK1A-related intellectual disability syndrome
GAND syndrome
intellectual developmental disorders, SMARCA2,4-related
intellectual disability, autosomal dominant 21
intellectual disability, autosomal dominant 34
intellectual disability, autosomal dominant 48
intellectual disability, autosomal dominant, CAMK2-related
intellectual disability, autosomal dominant 53
intellectual disability, autosomal dominant 54
intellectual disability, syndromic, autosomal dominant, ZMYND8-related
Kleefstra syndrome 1
Koolen-De Vries syndrome
Luo-Schoch-Yamamoto syndrome
NESCAV syndrome
intellectual disability, autosomal recessive
intellectual disability, autosomal recessive 2
intellectual disability, autosomal recessive 5
intellectual disability, autosomal recessive 37
intellectual disability, autosomal recessive 46
intellectual disability, autosomal recessive 56
intellectual disability, autosomal recessive 65
intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
intellectual disability, BRWD-related
intellectual disability, KDM5-related
intellectual disability, autosomal recessive 65
intellectual disability, X-linked, syndromic, Claes-Jensen type
intellectual disability, syndromic, autosomal dominant, ZMYND8-related
intellectual disability, syndromic, PPFIA3-related
intellectual disability with brain malformation, autosomal dominant, YWHAZ-related
intellectual disability, X-linked, nonsyndromic
intellectual disability, X-linked 9
intellectual disability, X-linked 63
intellectual disability, X-linked 106
intellectual disability, X-linked, syndromic
fragile X syndrome
intellectual disability, X-linked, CASK-related
intellectual disability, X-linked, MICPCH syndrome
intellectual disability, X-linked, FG syndrome 4
intellectual disability, X-linked, syndromic 13
intellectual disability, X-linked, syndromic 34
intellectual disability, X-linked, syndromic, Claes-Jensen type
intellectual disability, X-linked, syndromic, Hedera type
intellectual disability, X-linked, syndromic, Lubs type
intellectual disability, X-linked, syndromic, Nascimento type
intellectual disability, X-linked, syndromic, Snyder-Robinson type
intellectual disability, X-linked, syndromic, Turner type
intellectual disability, X-linked, with cerebellar hypoplasia and distinctive facial appearance
Renpenning syndrome 1
intellectual disability (postulated), BOD1-related
intellectual disability (postulated), GPM6A-related
intestinal dysfunction, RET-related
Hirschsprung disease, susceptibility to, 1
intrauterine growth restriction, symmetrical, insulin-signaling-related
juvenile myelomonocytic leukemia
juvenile myelomonocytic leukemia, PTPN11-related
juvenile polyposis syndrome, TGF-beta/BMP signaling pathway
kidney disease (fly models overview)
branchiootorenal spectrum disorders, EYA1-related
branchiootorenal syndrome 1
branchiootic syndrome 1
cystic renal dysplasia, susceptibility to, BICC1-related
focal segmental glomerulosclerosis
focal segmental glomerulosclerosis 1
focal segmental glomerulosclerosis 3
focal segmental glomerulosclerosis 4, susceptibility to
focal segmental glomerulosclerosis 5
Galloway-Mowat syndrome 3
high-fat diet, kidney disease
high-sugar diet, nephropathy
intellectual disability, syndromic, with renal and cardiac dysfunction, ADD3-KAT2B-related
kidney disease, PAN-induced
kidney disease (postulated), AMN-related
kidney disease (postulated), CDC42-related
kidney disease (postulated), CUBN-related
kidney disease (postulated), NFATC1-related
kidney disease (postulated), PALS1-related
kidney disease (postulated), RGS14-related
kidney disease (postulated), SRC-kinase-related
kidney stone disease, chemically-induced
kidney stone disease, V-ATPase models
nephrotic syndrome
nephrotic syndrome, KANK-related
nephrotic syndrome, type 16
nephrotic syndrome, KIRREL-related
nephrotic syndrome, type 23
nephrotic syndrome, type 1
nephrotic syndrome, type 2
nephrotic syndrome, type 9
nephrotic syndrome, type 12
nephrotic syndrome, type 14
nephrotic syndrome, type 19
nephrotic syndrome, type 20
nephrotic syndrome, type 23
nephrotic syndrome related to coenzyme Q deficiency
nephrotic syndrome (postulated), GAPVD1-related
nephrotic syndrome (postulated), stomatin-related
polycystic kidney disease
polycystic kidney disease 2
renal fibrosis, steroid-induced
xanthinuria, type I
Kleefstra syndrome
Kleefstra syndrome 1
Kleefstra syndrome 2
Kohlschutter-Tonz syndrome
Koolen-De Vries syndrome
Kufor-Rakeb syndrome (PARK9)
L1 syndrome
laminopathies
dilated cardiomyopathy 1A
Hutchinson-Gilford progeria syndrome
muscular dystrophy, lamin-related
muscular dystrophy, congenital, LMNA-related
Emery-Dreifuss muscular dystrophy 2
Emery-Dreifuss muscular dystrophy 3
Leber congenital amaurosis
Leber congenital amaurosis 7
Leber congenital amaurosis 8
Leber congenital amaurosis (postulated), PNPLA6-related
Leber hereditary optic neuropathy
Leber hereditary optic neuropathy, MT-ND2-related
Leigh syndrome
Leigh syndrome, MT-ATP6-related
Leigh syndrome, MT-ND2-related
Leishmania species infection
leptin deficiency or dysfunction
leukodystrophy, hypomyelinating
leukodystrophy, hypomyelinating, 5
leukodystrophy, hypomyelinating, 18
leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy
leukodystrophy, demyelinating, adult-onset, autosomal dominant
leukodystrophy with ataxia and sensorineural deafness
Lewy body dementia, SNCA-related
Lewy body dementia, susceptibility to, GBA1-related
Li-Fraumeni syndrome 1
lipodystrophy, congenital generalized
lipodystrophy, congenital generalized, type 2
lipodystrophy, familial partial
lipodystrophy, familial partial, type 2
lipotoxic cardiomyopathy, ceramide/sphingolipid-related
lissencephaly
lissencephaly 6 with microcephaly
lissencephaly 8
Listeria monocytogenes infection
liver disease (fly models overview)
metabolic dysfunction-associated steatotic liver disease
long QT syndrome
long QT syndrome 1
long QT syndrome 2
long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
Lowe oculocerebrorenal syndrome
lung cancer, adenocarcinoma, KIF5B-RET fusion
lung cancer, RAS-PTEN-related
Luo-Schoch-Yamamoto syndrome
lysosomal storage disorder (postulated), SPNS-related
Machado-Joseph disease (SCA3)
macrocephaly-autism syndrome
macular retinal dystrophy, North Carolina type, PRDM13-related
maple syrup urine disease, type II
maturity-onset diabetes of the young
Fanconi renotubular syndrome 4 with MODY
maturity-onset diabetes of the young, type 1
maturity-onset diabetes of the young, type 2
megaloblastic anemia 1
Meier-Gorlin syndrome
Meier-Gorlin syndrome 2
Meier-Gorlin syndrome 3
Menkes disease
MEPAN syndrome
metabolic dysfunction-associated steatotic liver disease
microcephalic primordial dwarfism
Meier-Gorlin syndrome
Meier-Gorlin syndrome 2
Meier-Gorlin syndrome 3
microcephalic dwarfism syndromes, DONSON-related
microcephaly, short stature, and limb abnormalities
microcephaly, primary
microcephaly 1, primary, autosomal recessive
microcephaly 2, primary, autosomal recessive
microcephaly 5, primary, autosomal recessive
microcephaly 16, primary, autosomal recessive
microcephaly 17, primary, autosomal recessive
microcephaly 18, primary, autosomal dominant
microcephaly, centrosome-SAC dysfunction
microcephaly 3, primary, autosomal recessive
microcephaly 6, primary, autosomal recessive
pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures
microcephaly, Zika virus-related
migraine, familial hemiplegic 1
migraine, familial hemiplegic 2
Mitchell syndrome
mitochondrial complex I deficiency, nuclear type
mitochondrial complex I deficiency, nuclear type 1
mitochondrial complex I deficiency, nuclear type 2
mitochondrial complex I deficiency, nuclear type 3
mitochondrial complex I deficiency, nuclear type 4
mitochondrial complex I deficiency, nuclear type 5
mitochondrial complex I deficiency, nuclear type 11
mitochondrial complex I deficiency, nuclear type 17
mitochondrial complex I deficiency, nuclear type 18
mitochondrial complex I deficiency, nuclear type 22
mitochondrial complex I disorders, MT-ND2-related
Leber hereditary optic neuropathy, MT-ND2-related
Leigh syndrome, MT-ND2-related
mitochondrial complex II deficiency, nuclear type
mitochondrial complex II deficiency, nuclear type 1
mitochondrial complex II deficiency, nuclear type 4
mitochondrial complex II deficiency (postulated), SDHAF4-related
mitochondrial complex III deficiency, nuclear type
mitochondrial complex III deficiency, nuclear type 1
mitochondrial complex III deficiency, nuclear type 2
mitochondrial complex IV deficiency, nuclear type
mitochondrial complex IV deficiency, nuclear type 1
mitochondrial complex IV deficiency, nuclear type, SCO1,2-related
mitochondrial complex IV deficiency, nuclear type 2
mitochondrial complex IV deficiency, nuclear type 4
mitochondrial complex IV deficiency, nuclear type 5
mitochondrial complex IV deficiency, nuclear type 17
mitochondrial complex IV disorder (postulated), CEP89-related
mitochondrial complex IV dysfunction, general model
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
mitochondrial complex IV disorders, MT-CO1-related
mitochondrial complex V (ATP synthase) deficiency, nuclear type
mitochondrial complex V (ATP synthase) deficiency, nuclear type, ATP5MC model
mitochondrial complex V (ATP synthase) deficiency, nuclear type 5
mitochondrial complex V disorders, MT-ATP6-related
Leigh syndrome, MT-ATP6-related
myopathy, lactic acidosis, and sideroblastic anemia 3
neuropathy, ataxia, and retinitis pigmentosa
striatonigral degeneration, infantile, mitochondrial
mitochondrial disease with seizure-sensitivity and hearing loss (postulated), MRPS12-related
mitochondrial disease and seizure sensitivity, SLC25A4(ANT1)-related
mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 2
mitochondrial disorders, VDAC-related
mitochondrial DNA depletion syndrome
Alpers-Huttenlocher syndrome
mitochondrial DNA depletion syndrome 4B (MNGIE type)
mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
mitochondrial DNA depletion syndrome 9
mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive
mitochondrial DNA depletion syndrome 17
mitochondrial pyruvate carrier deficiency
mitochondrial respiratory complex disease, mitochondrial types
mitochondrial trifunctional protein deficiency
mitochondrial trifunctional protein deficiency, HADHA-related
mitochondrial trifunctional protein deficiency, HADHB-related
motor neuron disease (postulated), WRAP53-related
motor neuron disease (postulated), VPS54-related
mtDNA polymerase disorders, POLG-related
Alpers-Huttenlocher syndrome
mitochondrial DNA depletion syndrome 4B (MNGIE type)
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 1
progressive external ophthalmoplegia with mtDNA deletions, autosomal recessive 1
sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
mucolipidosis IV
mucopolysaccharidoses
mucopolysaccharidosis type I
mucopolysaccharidosis type IIIA
mucopolysaccharidosis type IIIB
mucopolysaccharidosis type IIIC
mucopolysaccharidosis type VII
multiple acyl-CoA dehydrogenase deficiency
multiple acyl-CoA dehydrogenase deficiency, ETFDH-related
multiple endocrine neoplasia
multiple endocrine neoplasia, type I
multiple endocrine neoplasia, type IIA
multiple endocrine neoplasia, type IIB
multiple myeloma, DIS3-related
multiple sulfatase deficiency
multisystemic disorder with developmental delay, skeletal, cardiac, and neurological abnormalities, TMEM208-related
muscle and aortic defects, ARIH1-related
muscular dystrophy
fascioscapulohumeral muscular dystrophy, DUX4-related
fascioscapulohumeral muscular dystrophy, FRG1-related
muscular dystrophy, DAG1-related
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
muscular dystrophy, dystrophin-related
Becker muscular dystrophy
Duchenne muscular dystrophy
muscular dystrophy, Emery-Dreifuss
Emery-Dreifuss muscular dystrophy 2
Emery-Dreifuss muscular dystrophy 3
Emery-Dreifuss muscular dystrophy, LINC-complex-related
muscular dystrophy, lamin-related
Emery-Dreifuss muscular dystrophy 2
Emery-Dreifuss muscular dystrophy 3
muscular dystrophy, congenital, LMNA-related
muscular dystrophy, limb-girdle, autosomal dominant
muscular dystrophy, limb-girdle, autosomal dominant 2
muscular dystrophy, limb-girdle, autosomal dominant 3
muscular dystrophy, limb-girdle, autosomal recessive
muscular dystrophy-dystroglycanopathy (limb-girdle), type C1
muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
muscular dystrophy-dystroglycanopathy (limb-girdle), type C9
muscular dystrophy, limb-girdle, type 2C
muscular dystrophy, limb-girdle, type 2F
muscular dystrophy, limb-girdle, type 2H
muscular dystrophy, limb-girdle, type 2Z
muscular dystrophy, POMT1-related
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
muscular dystrophy-dystroglycanopathy (limb-girdle), type C1
muscular dystrophy, POMT2-related
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
muscular dystrophy-dystroglycanopathy (limb-girdle), type C2
muscular dystrophy, sarcoglycan-related D,G
muscular dystrophy, limb-girdle, type 2C
muscular dystrophy, limb-girdle, type 2F
muscular dystrophy, TRIM-gene-related
muscular dystrophy, limb-girdle, type 2H
muscular dystrophy-dystroglycanopathy
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
myotonic dystrophy
myotonic dystrophy 1
myotonic dystrophy 2
oculopharyngeal muscular dystrophy
Mycobacterium species infection
myeloproliferative disorders, JAK2-related
MYH9-related disorder
myoclonic-atonic epilepsy
myopathy, areflexia, respiratory distress, and dysphagia, early-onset
myopathy, congenital
congenital myopathy 6 with ophthalmoplegia
congenital myopathy 7A, myosin storage, autosomal dominant
congenital myopathy 7B, myosin storage, autosomal recessive
myopathy, congenital, ACTA1-related
congenital myopathy 2C, severe infantile, autosomal dominant
nemaline myopathy 3
myopathy, distal, 1
myopathy, distal, 4
myopathy, FLNC-related
myopathy, lactic acidosis, and sideroblastic anemia
myopathy, lactic acidosis, and sideroblastic anemia 2
myopathy, lactic acidosis, and sideroblastic anemia 3
myopathy, miR-9-related
myopathy, MYH-class-II-related
cardiomyopathy, MYH6-MYH7-related
congenital myopathy 6 with ophthalmoplegia
congenital myopathy 7A, myosin storage, autosomal dominant
congenital myopathy 7B, myosin storage, autosomal recessive
myopathy, myofibrillar
myopathy, myofibrillar, 2
myopathy, myofibrillar, 4
myopathy, myofibrillar, 5
myopathy with extrapyramidal signs
myopathy, statin-induced
myopathy with rimmed vacuoles, TARDBP-related
myotonic dystrophy
myotonic dystrophy 1
myotonic dystrophy 2
nemaline myopathy
nemaline myopathy 3
nemaline myopathy 4
nemaline myopathy 7
nephrotic syndrome
nephrotic syndrome, KANK-related
nephrotic syndrome, type 16
nephrotic syndrome, KIRREL-related
nephrotic syndrome, type 23
nephrotic syndrome, type 1
nephrotic syndrome, type 2
nephrotic syndrome, type 9
nephrotic syndrome, type 12
nephrotic syndrome, type 14
nephrotic syndrome, type 19
nephrotic syndrome, type 20
nephrotic syndrome, type 23
nephrotic syndrome related to coenzyme Q deficiency
nephrotic syndrome (postulated), GAPVD1-related
nephrotic syndrome (postulated), stomatin-related
NESCAV syndrome
Nestor-Guillermo progeria syndrome
neural and muscular diseases (fly methods and biology)
neural tube defect, VANGL1/2-related
neuroblastoma, susceptibility to, 3
neurodegeneration, activity dependent, DEGS-related
leukodystrophy, hypomyelinating, 18
neurodegeneration, childhood-onset, with brain atrophy
neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures
neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
neurodegeneration with brain iron accumulation
neurodegeneration with brain iron accumulation 1
neurodegeneration with brain iron accumulation 2A
neurodegeneration with brain iron accumulation 2B
neurodegeneration with brain iron accumulation 4
neurodegeneration with brain iron accumulation 6
neurodegenerative disease, ACOX1-related
Mitchell syndrome
peroxisomal acyl-CoA oxidase deficiency
neurodegenerative disease, AFG3L2-related
optic atrophy 12
spastic ataxia 5, autosomal recessive
spinocerebellar ataxia 28
neurodegenerative disease, arcRNA-related
neurodegenerative disease, C19orf12-related
neurodegenerative disease, CHCHD2,10-related
frontotemporal dementia and/or amyotrophic lateral sclerosis 2
Parkinson disease 22
spinal muscular atrophy, Jokela type
neurodegenerative disease, FIG4-related
amyotrophic lateral sclerosis 11
Charcot-Marie-Tooth disease, type 4J
Yunis-Varon syndrome
neurodegenerative disease, KIF5-related
neurodegenerative disease, lysosomal-autophagy pathway, MITF-TFE-related
neurodegenerative disease, miRNA-mediated glutamate receptor dysregulation in glia
neurodegenerative disease, MME-related
Charcot-Marie-Tooth disease, type 2T
spinocerebellar ataxia 43
neurodegenerative disease, NRDC-related
neurodegenerative disease, PLA2G6-related
neurodegeneration with brain iron accumulation 2A
neurodegeneration with brain iron accumulation 2B
Parkinson disease 14
neurodegenerative disease, PNPLA6-related
Boucher-Neuhauser syndrome
Leber congenital amaurosis (postulated), PNPLA6-related
Oliver-McFarlane syndrome
spastic paraplegia 39
neurodegenerative disease, SLC25A39,40-related
neurodegenerative disease, SQSTM1-related
frontotemporal dementia and/or amyotrophic lateral sclerosis 3
neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset
neurodegenerative disease, UBQLN-related
neurodegenerative disease, VPS13-related
chorea-acanthocytosis
Parkinson disease 23, early-onset
neurodegenerative disease of CoA-mtACP-PDH pathway, NDUFAB1 model
neurodegenerative disease (postulated), ABCG-related
neurodegenerative disease (postulated), AMPK-related
neurodegenerative disease (postulated), MIR137-related
neurodegenerative disease (postulated), NPLOC4-related
neurodegenerative disease (postulated), SLC17A/VGLUT-related
neurodegenerative disease, susceptibility to, SOX5-related
neurodegenerative disorders, ATP13A2-related
Kufor-Rakeb syndrome (PARK9)
spastic paraplegia 78
neurodevelopmental disorder, DXH9-related
neurodevelopmental disorder, EZH1-related
neurodevelopmental disorder, GTPBP1/GTPBP2-related
neurodevelopmental disorder, MRTFB-related
neurodevelopmental disorder, NSUN6-related
neurodevelopmental disorder, neural stem cell dedifferentiation
neurodevelopmental disorder, PRPF19-related
neurodevelopmental disorder, UNC79-related
neurodevelopmental disorder (postulated), DROSHA-related
neurodevelopmental disorder (postulated), WDR5-related
neurodevelopmental disorder with cerebellar atrophy and motor dysfunction
neurodevelopmental disorder with cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay
neurodevelopmental disorder with developmental delay, hypotonia, and impaired language
neurodevelopmental disorder with dysmorphic facies and behavioral abnormalities
neurodevelopmental disorder with dysmorphic facies and thin corpus callosum
neurodevelopmental disorder with eye movement abnormalities and ataxia
neurodevelopmental disorder with global developmental delay, DOT1L-related
neurodevelopmental disorder with hypotonia and speech delay, with or without seizures
neurodevelopmental disorder with intellectual disability, autistic features and language delay, with or without seizures
neurodevelopmental disorder with intellectual disability, hypotonia, impaired speech, and dysmorphic facies
neurodevelopmental disorder with language delay and seizures
neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy
neurodevelopmental disorder with motor and language delay, ocular defects, and brain abnormalities
neurodevelopmental disorder with or without autism or seizures
neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
neurodevelopmental disorder with severe developmental delay, intellectual disability, and behavioral abnormalities, CYFIP1-related
neurodevelopmental disorder with spasticity and poor growth
neurodevelopmental disorder with speech impairment and dysmorphic facies
neurodevelopmental disorders, FAT4-related
Hennekam lymphangiectasia-lymphedema syndrome 2
Van Maldergem syndrome 2
neurodevelopmental disorders, MECP2-related
encephalopathy, neonatal severe, MECP2-related
intellectual disability, X-linked, syndromic 13
intellectual disability, X-linked, syndromic, Lubs type
Rett syndrome
neurodevelopmental disorders (postulated), TAOK-related
autism spectrum disorder, susceptibility to (postulated), TAOK2-related
chromosome 16p11.2 deletion syndrome, 593-kb
neurodevelopmental disorders, susceptibility to (postulated), MIR22-related
neurodevelopmental disorders, susceptibility to (postulated), RBFOX-related
neurodevelopmental disorders, WDR81-related
neurodevelopmental syndrome with mild facial dysmorphia, SMARCA5-related
neurofibromatosis, type 1
neurological and neurodegenerative disease, ubiquitin pathways
neurological disorder with hypotonia, hyper-reflexia, ataxia, dystonia and white matter abnormalities, TOMM70-related
neurological disorders, ATP6AP2-related
neurological disorders, ATPalpha-related
migraine, familial hemiplegic 2
neurological disorders, GNAO1-related
developmental and epileptic encephalopathy 17
neurological disorders, MPV17-related
Charcot-Marie-Tooth disease, axonal, type 2EE
mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
neuromuscular disease, ATP2A-related
neuromuscular disease, DCTN1-related
neuromuscular disease, JPH-related
neuromuscular disease, MARS2-related
neuromuscular disease, MICU1-related
myopathy with extrapyramidal signs
neuromuscular diseases, TRPV4-related
neuronopathy, distal hereditary motor, autosomal dominant 8
neuropathy, hereditary motor and sensory, type IIC
scapuloperoneal spinal muscular atrophy
neuronal ceroid lipofuscinosis
neuronal ceroid lipofuscinosis 1
neuronal ceroid lipofuscinosis 3
neuronal ceroid lipofuscinosis 4
neuronal ceroid lipofuscinosis 7
neuronal ceroid lipofuscinosis 10
neuronal intranuclear inclusion disease
neuronal necrosis, calcium overload model
neuronopathy, distal hereditary motor
neuronopathy, distal hereditary motor, autosomal dominant 4
neuronopathy, distal hereditary motor, autosomal recessive 8
neuronopathy, distal hereditary motor, autosomal dominant 2
neuronopathy, distal hereditary motor, autosomal dominant 3
neuronopathy, distal hereditary motor, autosomal dominant 5
neuronopathy, distal hereditary motor, autosomal dominant 14
neuronopathy, distal hereditary motor, autosomal dominant 8
neuronopathy, distal hereditary motor, X-linked
neuronopathy, HSPB8-related
Charcot-Marie-Tooth disease, axonal, type 2L
neuronopathy, distal hereditary motor, autosomal dominant 2
neurooculocardiogenitourinary syndrome
neuropathy, ataxia, and retinitis pigmentosa
neuropathy, hereditary sensory and autonomic
neuropathy, hereditary sensory and autonomic, type IA
neuropathy, hereditary sensory and autonomic, type IC
neuropathy, hereditary sensory and autonomic, type VIII
neuropathy, hereditary sensory, type IIC
neuropathy, hereditary motor and sensory, type IIC
neuropathy, hereditary motor and sensory, type VIA
neuropathy, hereditary motor and sensory, type VIB
NFIA-related disorder
NGLY1 congenital disorder of deglycosylation
Niemann-Pick disease
Niemann-Pick disease, type A and B
Niemann-Pick disease, type C1
Niemann-Pick disease, type C2
night blindness, congenital stationary
night blindness, congenital stationary, 1B, autosomal recessive
Nijmegen breakage syndrome
nociceptive pain sensitization, injury-induced
Noonan syndrome
Noonan syndrome 1
Noonan syndrome 3
Noonan syndrome 5
Noonan syndrome 7
Noonan syndrome with multiple lentigines
Noonan syndrome with multiple lentigines 1
Noonan syndrome with multiple lentigines 2
NSD1 duplication syndrome
nystagmus, congenital
nystagmus 8, congenital, autosomal recessive
obesity, susceptibility to (fly models overview)
age-dependent ectopic fat accumulation, HDAC6-related
diabetes/obesity, impact of parental disease
high-fat diet, obesity
high-sugar diet, obesity
insulin signaling, regulation of fat storage, Drosophila fat body model
leptin deficiency or dysfunction
obesity and behavioral phenotypes (postulated), ETV5-related
obesity and cardiomyocyte regulation of systemic lipid levels, APOB-related
obesity and cardiomyocyte regulation of systemic lipid levels, MTTP-related
obesity and cardiomyocyte regulation of systemic lipid levels, role of SNAIL TF genes
obesity and diabetes type 1, susceptibility to (postulated), ITPR-related
obesity and metabolic disorder, starvation-resistant populations
obesity and metabolic disorder, susceptibility to (postulated), MIR33-related
obesity model, activation of Taotie neurons
obesity model, prolonged larval stage
obesity, body-fat sensor mechanisms, semaphorin-related
obesity, susceptibility to, adipokinetic hormone model
obesity, susceptibility to, TFAP2B-KCTD15-CCK regulation of feeding behavior
obesity, susceptibility to (postulated), ABHD4/5-related
obesity, susceptibility to (postulated), ceramide/sphingolipid-related
obesity, susceptibility to (postulated), CAPN8-related
obesity, susceptibility to (postulated), CORO7-related
obesity, susceptibility to (postulated), DNAH10-related
obesity, susceptibility to (postulated), FLII-related
obesity, susceptibility to (postulated), hedgehog signaling pathway
obesity, susceptibility to (postulated), Hippo signaling pathway
obesity, susceptibility to (postulated), MED12-related
obesity, susceptibility to (postulated), MED13-related
obesity, susceptibility to (postulated), neurotensin-related
obesity, susceptibility to (postulated), NKX6-3-related
obesity, susceptibility to (postulated), PLIN-related
obesity, susceptibility to (postulated), PLXND1-related
obesity, susceptibility to (postulated), PNPLA/ATGL-related
obesity, susceptibility to (postulated), SDK1-related
obesity, susceptibility to (postulated), SEC16B-related
obesity, susceptibility to (postulated), serotonin class 2 receptor(s)
obesity, susceptibility to (postulated), SNCAIP-related
obesity, susceptibility to (postulated), SPEN-related
obesity, susceptibility to (postulated), STIM1-related
obesity, susceptibility to (postulated), THADA-related
obesity, susceptibility to (postulated), WDTC1-related
obesity, susceptibility to (postulated), Wnt signaling pathway
occipital horn syndrome
oculopharyngeal muscular dystrophy
Oliver-McFarlane syndrome
operant self-learning disorders, FOXP-related
intellectual disability with language impairment and with or without autistic features
speech-language disorder 1
optic atrophy
optic atrophy syndromes, OPA1-related
optic atrophy 1
optic atrophy 12
optic atrophy plus syndrome
organophosphate-induced delayed neuropathy
ovarian dysgenesis
ovarian dysgenesis 6
ovarian dysgenesis 7
ovarian dysgenesis (postulated), BRCA2-related
oxoglutarate dehydrogenase deficiency
pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures
pancreatic carcinoma, multigenic
pancreatic islet amyloidosis, IAPP-related
panhypopituitarism, X-linked, with or without intellectual disability
Parkinson disease
Parkinson disease 1
Parkinson disease 2, early-onset
Parkinson disease 4
Parkinson disease 5, susceptibility to
Parkinson disease 6, early-onset
Parkinson disease 7, early-onset
Parkinson disease 8
Parkinson disease 11, susceptibility to
Parkinson disease 13, susceptibility to
Parkinson disease 14
Parkinson disease 15, early-onset
Parkinson disease 16 (postulated), RAB29-related
Parkinson disease 17
Parkinson disease 19A/B, early-onset
Parkinson disease 20, early-onset
Parkinson disease 22
Parkinson disease 23, early-onset
Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development
Parkinson disease (postulated), BOK-related
Parkinson disease (postulated), DNAJC13-related
Parkinson disease (postulated), FOXO-related
Parkinson disease (postulated), GPR37-related
Parkinson disease (postulated), IMMT-related
Parkinson disease (postulated), NSF-related
Parkinson disease (postulated), NUS1-related
Parkinson disease (postulated), PAK4-related
Parkinson disease (postulated), PGC-1-related
Parkinson disease (postulated), SNCAIP-related
Parkinson disease (postulated), TMEM230-related
Parkinson disease (postulated), TPPP-related
Parkinson disease (postulated), ZNF746-related
Parkinson disease, susceptibility plus toxin exposure
Parkinson disease, susceptibility to, AP2M1-related
Parkinson disease, susceptibility to, auxilin-related
Parkinson disease, susceptibility to, GBA1-related
Parkinson disease, susceptibility to, SH3GL2-related
Parkinson disease, susceptibility to, SREBF1-related
parkinsonism with polyneuropathy
Parkinson disease, iron overload
Parkinson-like disease, BPA-induced
Parkinson-like disease, metal toxicity
Parkinson-like disease, MPP-induced
Parkinson-like disease, toxin-induced
Parkinson-like disease (postulated), HSPA9-related
Parkinson-like model, Dmel_Fer2
Parkinson-like model, PGK-related
Parkinson-like model, proteasome-related
Parkinson-like model, RHOT/Miro-related
parkinsonism-dystonia, infantile 1
paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy
Perlman syndrome
peripheral neuropathy, drug-induced
peroxisomal acyl-CoA oxidase deficiency
peroxisome biogenesis disorder
peroxisome biogenesis disorder 1A
peroxisome biogenesis disorder 2A
peroxisome biogenesis disorder 3A
peroxisome biogenesis disorder 4A
peroxisome biogenesis disorder 5A
peroxisome biogenesis disorder 6A
peroxisome biogenesis disorder 8A
peroxisome biogenesis disorder 9B
peroxisome biogenesis disorder 10A
peroxisome biogenesis disorder 11A
peroxisome biogenesis disorder 12A
peroxisome biogenesis disorder 13A
peroxisome biogenesis disorder 14B
Perry syndrome
persistent alcohol cue memory
Pick disease
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
Pitt-Hopkins syndrome
Pitt-Hopkins-like syndrome 1
Pitt-Hopkins-like syndrome 2
pituitary adenoma 1, multiple types
polyalanine diseases
oculopharyngeal muscular dystrophy
polycystic kidney disease
polycystic kidney disease 2
polyglutamine diseases
dentatorubral-pallidoluysian atrophy
Huntington disease
Machado-Joseph disease (SCA3)
spinal and bulbar muscular atrophy, X-linked 1
spinocerebellar ataxia 1
spinocerebellar ataxia 2
spinocerebellar ataxia 7
spinocerebellar ataxia 8
spinocerebellar ataxia 12
spinocerebellar ataxia 17
polyglutamine diseases, polyQ models
pontocerebellar hypoplasia
pontocerebellar hypoplasia, type 1B
pontocerebellar hypoplasia, type 2A
pontocerebellar hypoplasia, type 4
pontocerebellar hypoplasia, type 5
pontocerebellar hypoplasia, type 10
pontocerebellar hypoplasia, TSEN54-related
porphyria-like (postulated), GBE1-related
primary ovarian insufficiency
primary ovarian insufficiency (postulated), MOV10-related
prion diseases
Creutzfeldt-Jakob disease, familial
fatal familial insomnia
Gerstmann-Straussler disease
progeroid syndrome
Hutchinson-Gilford progeria syndrome
Nestor-Guillermo progeria syndrome
Werner syndrome
progressive external ophthalmoplegia with mtDNA deletions
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 1
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 3
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 4
progressive external ophthalmoplegia with mtDNA deletions, autosomal recessive 1
progressive external ophthalmoplegia with mtDNA deletions, autosomal dominant 2
progressive supranuclear palsy 1
proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
prosaposin deficiency
prostate cancer
prostate cancer, E-cadherin-related
prostate cancer, N-cadherin-related
prostate cancer, PAX-related
prostate cancer model, Drosophila cell culture exposed to synthetic androgen
prostate cancer (postulated), astacin-related
prostate cancer (postulated), CNPY1,2-related
prostate cancer (postulated), MRGBP-related
pseudohypoaldosteronism, type II
pseudohypoaldosteronism, type II, WNK-related
pseudohypoaldosteronism, type IIB
pseudohypoaldosteronism, type IIC
Pseudomonas aeruginosa infection
pyridoxamine 5'-phosphate oxidase deficiency
pyruvate dehydrogenase complex deficiency
pyruvate dehydrogenase E1-beta deficiency
RASopathies, MAP2K1,2-related
cardiofaciocutaneous syndrome 3
cardiofaciocutaneous syndrome 4
reducing body myopathy 1A
renal fibrosis, steroid-induced
Renpenning syndrome 1
restless legs syndrome
restless legs syndrome 6 (postulated), BTBD9-related
retinal disease, inherited (fly models overview)
cone-rod dystrophy
cone-rod dystrophy 2
cone-rod dystrophy 12
Leber congenital amaurosis
Leber congenital amaurosis 7
Leber congenital amaurosis 8
Leber congenital amaurosis (postulated), PNPLA6-related
Leber hereditary optic neuropathy
Leber hereditary optic neuropathy, MT-ND2-related
macular retinal dystrophy, North Carolina type, PRDM13-related
retinal degeneration, excessive endocytosis of rhodopsin
retinal disease, CRB1-related
Leber congenital amaurosis 8
retinitis pigmentosa 12
retinal disease, CRX-related
cone-rod dystrophy 2
Leber congenital amaurosis 7
retinal disease, PROM1-related
cone-rod dystrophy 12
retinal macular dystrophy 2
retinitis pigmentosa 41
retinal disease, rhodopsin-related
retinitis pigmentosa 4
retinitis pigmentosa
retinitis pigmentosa 4
retinitis pigmentosa 11
retinitis pigmentosa 12
retinitis pigmentosa 13
retinitis pigmentosa 25
retinitis pigmentosa 41
retinitis pigmentosa 59
Rett syndrome
rhabdoid tumor predisposition syndrome 1
rhabdomyosarcoma 2, PAX7-FOXO1 fusion
rhabdomyosarcoma 2, PAX3-FOXO1 fusion
riboflavin transporter deficiency neuronopathy
Brown-Vialetto-Van Laere syndrome 1
Brown-Vialetto-Van Laere syndrome 2
RNA repeat diseases
fragile-X-related syndromes
fragile X syndrome
fragile X tremor/ataxia syndrome
Friedreich ataxia 1
frontotemporal dementia and/or amyotrophic lateral sclerosis 1
myotonic dystrophy 1
myotonic dystrophy 2
spinocerebellar ataxia 8
spinocerebellar ataxia 10
Robinow syndrome, autosomal dominant 2
Salmonella species infection
Sandestig-Stefanova syndrome
SARS-CoV-1,2 viral infection
scapuloperoneal spinal muscular atrophy
schizophrenia, susceptibility to
schizophrenia, dopamine ontogeny hypothesis
schizophrenia, susceptibility to, DISC1-related
schizophrenia, susceptibility to (postulated), BLOC1S1-related
schizophrenia, susceptibility to (postulated), DTNBP1-related
schizophrenia, susceptibility to (postulated), RIMS-related
Schimke immuno-osseous dysplasia
schwannomatosis, vestibular
Seckel syndrome 9
seizures, benign familial infantile
seizures, benign familial infantile, 3
seizure-sensitive (postulated), ETNK-related
seizure-sensitive (postulated), SLC12A1-3-related
seizure-sensitive (postulated), SLC24A-related
seizure-sensitive, potassium channel defects (eag, Sh model)
seizure-sensitive, potassium channel defects, KCNT1-2-related
developmental and epileptic encephalopathy 14
developmental and epileptic encephalopathy 57
epilepsy, nocturnal frontal lobe, 5
seizure-sensitive (postulated), UBE3A-related
seizure sensitive/resistant (postulated), PRKG1-related
seizure sensitivity, disruption during critical developmental period
seizure-sensitivity model, Dmel_jus
sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
Serratia marcescens infection
short stature, hearing loss, retinitis pigmentosa, and distinctive facies
Shwachman-Diamond syndrome 1
Siddiqi syndrome
Sindbis virus infection
SLC5A6-related disorders
Sotos syndrome 1
spastic ataxia
spastic ataxia 3, autosomal recessive
spastic ataxia 5, autosomal recessive
spastic paraplegia
dystonia, early-onset, and/or spastic paraplegia
spastic paraplegia 3A
spastic paraplegia 4
spastic paraplegia 7
spastic paraplegia 10
spastic paraplegia 12
spastic paraplegia 15
spastic paraplegia 17
spastic paraplegia 20
spastic paraplegia 30
spastic paraplegia 31, autosomal dominant
spastic paraplegia 35
spastic paraplegia 39
spastic paraplegia 43
spastic paraplegia 61
spastic paraplegia 76
spastic paraplegia 77
spastic paraplegia 78
spastic paraplegia 90A, autosomal dominant
spinal muscular atrophy
motor neuron disease (postulated), WRAP53-related
neuronopathy, distal hereditary motor, X-linked
spinal and bulbar muscular atrophy, X-linked 1
spinal muscular atrophy, Jokela type
spinal muscular atrophy, late onset, Finkel type
spinal muscular atrophy, lower extremity-predominant, 2
spinal muscular atrophy, SMN-related
spinal muscular atrophy, type I
spinal muscular atrophy, type II
spinal muscular atrophy, type III
spinal muscular atrophy, type IV
spinal muscular atrophy, SMN2-related therapy
spinocerebellar ataxia, autosomal dominant
dentatorubral-pallidoluysian atrophy
global developmental delay and congenital ataxia, CACNA1A-related
Machado-Joseph disease (SCA3)
spinocerebellar ataxia 1
spinocerebellar ataxia 2
spinocerebellar ataxia 5
spinocerebellar ataxia 6
spinocerebellar ataxia 7
spinocerebellar ataxia 8
spinocerebellar ataxia 10
spinocerebellar ataxia 12
spinocerebellar ataxia 13
spinocerebellar ataxia 14
spinocerebellar ataxia 15
spinocerebellar ataxia 17
spinocerebellar ataxia 28
spinocerebellar ataxia 29
spinocerebellar ataxia 31
spinocerebellar ataxia 35
spinocerebellar ataxia 43
spinocerebellar ataxia, autosomal recessive
neurodevelopmental disorder with spasticity and poor growth
spinocerebellar ataxia autosomal recessive 4
spinocerebellar ataxia autosomal recessive 14
spinocerebellar ataxia autosomal recessive 21
spinocerebellar ataxia autosomal recessive 24 (postulated)
spinocerebellar ataxia autosomal recessive 25 (postulated)
spinocerebellar ataxia autosomal recessive 27
spinocerebellar ataxia autosomal recessive 32
spinocerebellar ataxia autosomal recessive (postulated), UFM1-related
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
spondyloarthropathy, susceptibility to
spondyloarthropathy, susceptibility to, 1
Staphylococcus aureus infection
Stolerman neurodevelopmental syndrome
Streptococcus species infection
striatonigral degeneration, infantile, mitochondrial
sulfite oxidase deficiency, isolated
synaptic dysfunction, KIF1-related
NESCAV syndrome
neuropathy, hereditary sensory, type IIC
spastic paraplegia 30
synaptic transmission defects, IDH3A-related
TANGO2-related metabolic encephalopathy and arrhythmias
tauopathies
tauopathies, heterochromatin decondensation and transposable element dysregulation
tauopathies, MAPT-related
frontotemporal dementia with parkinsonism 17
Pick disease
progressive supranuclear palsy 1
TBC1D24-related disorders
DOORS syndrome
epilepsy, rolandic, with paroxysmal exercise-induced dystonia
thyroid carcinoma, familial medullary
multiple endocrine neoplasia
thyroid carcinoma, nonmedullary
Townes-Brocks syndrome
toxicity studies (fly models overview)
traumatic brain injury and chronic traumatic encephalopathy
trichothiodystrophy
trichothiodystrophy 1, photosensitive
triosephosphate isomerase deficiency
tuberous sclerosis complex
tuberous sclerosis 1
tuberous sclerosis 2
type IV collagenopathies
ulcerative colitis-like, chemically induced
uric acid nephrolithiasis, Dmel_CG10939 model
Usher syndrome
Usher syndrome, type I
Usher syndrome, type IJ
Usher syndrome, deafness, MYO7A-related
deafness, autosomal dominant 11
deafness, autosomal recessive 2
Usher syndrome, type I
Van Maldergem syndrome 2
vertebral anomalies and variable endocrine and T-cell dysfunction
vertebral hypersegmentation and orofacial anomalies
Vibrio cholerae infection
Vici syndrome
viral infection, susceptibility to (postulated), EHMT-related
visceral myopathy (postulated), MSTO1-related
visual impairment and progressive phthisis bulbi
Vissers-Bodmer syndrome
von Hippel-Lindau syndrome
Wallerian degeneration
Warburg micro syndrome
Warburg micro syndrome 2
Werner syndrome
WFS1-related disorders
Wolfram syndrome 1
White-Sutton syndrome
Williams-Beuren syndrome
Williams-Beuren syndrome, LIMK1-related
Wilson disease
Wolfram syndrome 1
xanthinuria, type I
xeroderma pigmentosum
xeroderma pigmentosum, complementation group B
xeroderma pigmentosum, complementation group D
xeroderma pigmentosum, variant type
Yoon-Bellen neurodevelopmental syndrome
Yunis-Varon syndrome